Please login to the form below
Research Partnership launches new patient Living With Non-alcoholic Steatohepatitis (NASH) report
Living with Non-alcoholic Steatohepatitis (NASH) is a study conducted amongst 100 adults with NASH in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase summer 2017.
The report is intended to help pharmaceutical companies developing products in this disease area to gain a deeper understanding of how patients come to be diagnosed with NASH, how it impacts their day-to-day lives and what their attitudes and perceptions are towards the management of their condition. It will also uncover attitudes towards NASH compared to other co-morbid conditions such as diabetes and obesity.
Find out more https://www.researchpartnership.com/news/2017/05/living-with-nash-launched/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Healthcare in the age of AI: How will artificial intelligence impact future decision-making?
- Authored by: Constanza Salas, Jhon Galindo and Rachel Howard
Research Partnership
- Therapy Watch launches new tracker covering Postpartum Depression
- The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry
Research Partnership
- Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market
- Authored by: Marc Garcia and Tania Rodrigues
Research Partnership
- Infographic: Rare Diseases in China
- How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.
Research Partnership
- New syndicated COPD report now available
- Living with COPD 2023
Research Partnership
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics.
Research Partnership
